[Federal Register Volume 70, Number 64 (Tuesday, April 5, 2005)]
[Notices]
[Pages 17261-17262]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-6698]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 21, 2004, and published in the Federal 
Register on January 4, 2005, (70 FR 391), Houba, Inc., P.O. Box 190, 
16235 State Road 17, Culver, Indiana 46511, made application by renewal 
to the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed in 
Schedule II; and by letter dated October 1, 2004, to modify its name to 
Acura Pharmaceutical Technologies, Inc., and change the address by 
removing the P.O. Box 190.

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.

[[Page 17262]]

    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Houba, Inc., to manufacture the listed basic classes of controlled 
substances is consistent with the public interest at this time. DEA has 
investigated Houba, Inc., to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with State and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33(a), the above 
named company is granted registration as a bulk manufacturer of the 
basic classes of controlled substances listed.

    Dated: March 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-6698 Filed 4-4-05; 8:45 am]
BILLING CODE 4410-09-P